Wolverine Trading
NAVB

Wolverine Trading’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Wolverine Trading’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-20,000
Closed -$6K – 5252
2023
Q1 		$6K Hold
20,000
– – ﹤0.01% 4100
2022
Q4 		$4K Buy
+20,000
New +$5K ﹤0.01% 3841
2022
Q2 		– Sell
-10,300
Closed -$8K – 6252
2022
Q1 		$8K Sell
10,300
-6,000
-37% -$5.5K ﹤0.01% 5304
2021
Q4 		$17K Buy
16,300
+5,600
+52% +$7.88K ﹤0.01% 5519
2021
Q3 		$18K Buy
+10,700
New +$18K ﹤0.01% 6156
2021
Q2 		– Sell
-17,800
Closed -$36K – 7154
2021
Q1 		$36K Buy
17,800
+2,100
+13% +$4.92K ﹤0.01% 5713
2020
Q4 		$31K Buy
15,700
+1,400
+10% +$3.3K ﹤0.01% 4665
2020
Q3 		$41K Sell
14,300
-5,700
-29% -$20.5K ﹤0.01% 4304
2020
Q2 		$76K Buy
20,000
+3,900
+24% +$7.46K ﹤0.01% 4225
2020
Q1 		$13K Sell
16,100
-4,100
-20% -$4.52K ﹤0.01% 4466
2019
Q4 		$25K Buy
+20,200
New +$17.4K ﹤0.01% 4539
2017
Q4 		– Sell
-605
Closed -$5K – 5851
2017
Q3 		$5K Sell
605
-50
-8% -$424 ﹤0.01% 4328
2017
Q2 		$7K Buy
+655
New +$6.48K ﹤0.01% 4177
2017
Q1 		– Sell
-605
Closed -$8K – 5374
2016
Q4 		$8K Buy
+605
New +$9.6K ﹤0.01% 4347

Other funds holding NAVB

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return

Wolverine Trading's NAVB Position: Q2 2023 in Review

Wolverine Trading sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q2 2023, closing a stake of 16,297 shares — an estimated $5K sold.

Wolverine Trading first reported a position in NAVB in Q2 2017 and held it in 9 quarters. The position peaked at $60K in Q2 2020. 23 funds tracked by Wall St. Rank hold NAVB as of Q2 2023.

  • Wolverine Trading reported no remaining Navidea Biopharmaceuticals Inc. position as of Q2 2023 after selling out during the quarter.
  • Wolverine Trading sold 16,297 Navidea Biopharmaceuticals Inc. shares in Q2 2023, an estimated $5K.
  • Wolverine Trading first reported a position in Navidea Biopharmaceuticals Inc. in Q2 2017 and held it in 9 quarters.
  • Wolverine Trading's Navidea Biopharmaceuticals Inc. position peaked at $60K in Q2 2020.
  • 23 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q2 2023.

Based on Wolverine Trading's 13F filing for Q2 2023, filed 23 Aug 2023.